633 related articles for article (PubMed ID: 35264666)
21. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
22. Qualitative and quantitative assessment of sperm miRNAs identifies hsa-miR-9-3p, hsa-miR-30b-5p and hsa-miR-122-5p as potential biomarkers of male infertility and sperm quality.
Joshi M; Andrabi SW; Yadav RK; Sankhwar SN; Gupta G; Rajender S
Reprod Biol Endocrinol; 2022 Aug; 20(1):122. PubMed ID: 35971175
[TBL] [Abstract][Full Text] [Related]
23. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
Wang K; Chen M; Wu W
World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
[TBL] [Abstract][Full Text] [Related]
24. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y
Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM.
Elango R; Alsaleh KA; Vishnubalaji R; Manikandan M; Ali AM; Abd El-Aziz N; Altheyab A; Al-Rikabi A; Alfayez M; Aldahmash A; Alajez NM
Front Oncol; 2020; 10():756. PubMed ID: 32509578
[TBL] [Abstract][Full Text] [Related]
26. A data-driven biocomputing pipeline with meta-analysis on high throughput transcriptomics to identify genome-wide miRNA markers associated with type 2 diabetes.
De Silva K; Demmer RT; Jönsson D; Mousa A; Forbes A; Enticott J
Heliyon; 2022 Feb; 8(2):e08886. PubMed ID: 35169647
[TBL] [Abstract][Full Text] [Related]
27. [miRNA Expression Profile in Ileocecal Adenocarcinoma Cells Infected with Cryptosporidium].
Ulusan Bağcı Ö; Caner A
Mikrobiyol Bul; 2022 Jul; 56(3):449-465. PubMed ID: 35960237
[TBL] [Abstract][Full Text] [Related]
28. Differential microRNA expression in the peripheral blood from human patients with COVID-19.
Li C; Hu X; Li L; Li JH
J Clin Lab Anal; 2020 Oct; 34(10):e23590. PubMed ID: 32960473
[TBL] [Abstract][Full Text] [Related]
29. An evolutionary learning-based method for identifying a circulating miRNA signature for breast cancer diagnosis prediction.
Sathipati SY; Tsai MJ; Aimalla N; Moat L; Shukla SK; Allaire P; Hebbring S; Beheshti A; Sharma R; Ho SY
NAR Genom Bioinform; 2024 Mar; 6(1):lqae022. PubMed ID: 38406797
[TBL] [Abstract][Full Text] [Related]
30. Abnormal regulation of microRNAs and related genes in pediatric β-thalassemia.
Wang H; Chen M; Xu S; Pan Y; Zhang Y; Huang H; Xu L
J Clin Lab Anal; 2021 Sep; 35(9):e23945. PubMed ID: 34398996
[TBL] [Abstract][Full Text] [Related]
31. Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.
Ntoumou E; Tzetis M; Braoudaki M; Lambrou G; Poulou M; Malizos K; Stefanou N; Anastasopoulou L; Tsezou A
Clin Epigenetics; 2017; 9():127. PubMed ID: 29255496
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel circulating miRNAs biomarkers for healthy obese and lean children.
Ma F; Cao D; Liu Z; Li Y; Ouyang S; Wu J
BMC Endocr Disord; 2023 Oct; 23(1):238. PubMed ID: 37904219
[TBL] [Abstract][Full Text] [Related]
33. miRNA-Seq Tissue Diagnostic Signature: A Novel Model for NSCLC Subtyping.
Charkiewicz R; Sulewska A; Charkiewicz A; Gyenesei A; Galik B; Ramlau R; Piwkowski C; Stec R; Biecek P; Karabowicz P; Michalska-Falkowska A; Miltyk W; Niklinski J
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686123
[TBL] [Abstract][Full Text] [Related]
34. Identification of the differential expression of genes and upstream microRNAs in small cell lung cancer compared with normal lung based on bioinformatics analysis.
Li X; Ma C; Luo H; Zhang J; Wang J; Guo H
Medicine (Baltimore); 2020 Mar; 99(11):e19086. PubMed ID: 32176034
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer.
Jakob M; Mattes LM; Küffer S; Unger K; Hess J; Bertlich M; Haubner F; Ihler F; Canis M; Weiss BG; Kitz J
Head Neck; 2019 Oct; 41(10):3499-3515. PubMed ID: 31355988
[TBL] [Abstract][Full Text] [Related]
36. Identification of circulating miRNAs as novel prognostic biomarkers for bladder cancer.
Lin GB; Zhang CM; Chen XY; Wang JW; Chen S; Tang SY; Yu TQ
Math Biosci Eng; 2019 Nov; 17(1):834-844. PubMed ID: 31731380
[TBL] [Abstract][Full Text] [Related]
37. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
[TBL] [Abstract][Full Text] [Related]
38. Dysregulation of microRNA expression during the progression of colorectal tumors.
Eizuka M; Osakabe M; Sato A; Fujita Y; Tanaka Y; Otsuka K; Sasaki A; Matsumoto T; Suzuki H; Sugai T
Pathol Int; 2020 Sep; 70(9):633-643. PubMed ID: 32592277
[TBL] [Abstract][Full Text] [Related]
39. Hsa-let-7c-5p, hsa-miR-130b-3p, and hsa-miR-142-3p as Novel miRNA Biomarkers for Melanoma Progression.
Wu X; Wang Y; Chen C; Xue Y; Zheng S; Cai L
Genet Res (Camb); 2022; 2022():5671562. PubMed ID: 35903462
[TBL] [Abstract][Full Text] [Related]
40. Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures.
Yerukala Sathipati S; Huang HL; Ho SY
BMC Genomics; 2016 Dec; 17(Suppl 13):1022. PubMed ID: 28155650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
